| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.47 | 0.01 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |